(function(doc, html, url) {
var widget = doc.createElement("div");
widget.innerHTML = html;
var script = doc.currentScript; // e = a.currentScript;
if (!script) {
var scripts = doc.scripts;
for (var i = 0; i < scripts.length; ++i) {
script = scripts[i];
if (script.src && script.src.indexOf(url) != -1) break;
}
}
script.parentElement.replaceChild(widget, script);
}(document, '
SLPs and Cancer-Related Cognitive Impairment: Gaps in Knowledge and Training
What is it about?
This study looks at how speech-language pathologists (SLPs) understand and address cognitive problems caused by cancer and its treatments, often called "chemo brain" or cancer-related cognitive impairment (CRCI). Researchers surveyed SLPs to learn about their knowledge, training, and clinical practices related to CRCI. The findings suggest that many SLPs recognize CRCI as an important issue, but there are gaps in their training and confidence in treating it. Some SLPs receive referrals for patients with CRCI, but standardized assessment and treatment approaches are not widely used. The study highlights the need for better education and resources to help SLPs support individuals experiencing cognitive difficulties due to cancer.
Why is it important?
This work is important because it highlights a critical gap in healthcare: many speech-language pathologists (SLPs) are not fully prepared to assess and treat cognitive problems caused by cancer and its treatments, known as cancer-related cognitive impairment (CRCI). People with cancer often experience memory issues, trouble concentrating, and difficulty processing information, which can impact their daily lives, work, and relationships. SLPs have the skills to help, but many lack the training or resources to provide effective support. By identifying these gaps, this study helps push for better education, standardized assessments, and stronger clinical guidelines—ultimately improving care for cancer survivors dealing with cognitive challenges.